phase readout
saveNCT06561386: A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Bristol-Myers Squibb. Phase: PHASE3. Conditions: Non-small Cell Lung Cancer
view source ↗
comments(0)
5-min edit window · permanent after that